A Study Evaluating the Efficacy and Safety of SM04554 Topical Solution in Male Subjects With Androgenetic Alopecia

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

675

Participants

Timeline

Start Date

November 1, 2018

Primary Completion Date

December 31, 2020

Study Completion Date

December 31, 2020

Conditions
Androgenetic Alopecia
Interventions
DRUG

Topical SM04554 solution

Study medication application will be performed by the individual subject at approximately the same time each day.

DRUG

Topical SM04554 solution

Study medication application will be performed by the individual subject at approximately the same time each day.

DRUG

Topical vehicle solution

Vehicle solution application will be performed by the individual subject at approximately the same time each day.

Trial Locations (14)

16059

Research Site, Bursa

20070

Research Site, Denizli

33343

Research Site, Mersin

34098

Research Site, Istanbul

34668

Research Site, Istanbul

35180

Research Site, Izmir

38039

Research Site, Kayseri

41380

Research Site, Kocaeli

55139

Research Site, Samsun

61080

Research Site 1, Trabzon

Research Site 2, Trabzon

06100

Research Site, Ankara

06110

Research Site, Ankara

06680

Research Site, Ankara

Sponsors
All Listed Sponsors
lead

Biosplice Therapeutics, Inc.

INDUSTRY

NCT03742518 - A Study Evaluating the Efficacy and Safety of SM04554 Topical Solution in Male Subjects With Androgenetic Alopecia | Biotech Hunter | Biotech Hunter